College students are inundated with warnings about HIV and chlamydia, but one common and potentially life-threatening sexually transmitted disease (STD) goes largely unnoticed.
Human papillomavirus (HPV), more commonly referred to as genital warts, is one of the most widespread STDs and can also lead to cervical cancer. What many Harvard students may not know is that HPV cannot always be prevented with the use of condoms.
HPV at Large
Cervical cancer kills 5,000 American women a year, and in countries where women do not have easy access to Pap smear tests, papillomavirus-related cervical cancer is the number one cause of cancer-related death.
Of the more than 50 different strains of HPV, some only cause warts, but others have been conclusively linked to pre-malignant and malignant growths in the cervix.
Two genes in the virus, E6 and E7, attach to proteins that regulate cell division and deactivate them. HPV causes the cells to grow wildly and also destroys the mechanisms that would normally fix the problem.
The first noticeable cellular difference in the cervix is subtle change in the shape of cells as they begin to enlarge. Later, the standard arrangement of cells gets destroyed as diseased cells begin to grow out of control.
Read more in News
All Proves A-OK at Harvard After Y2KRecommended Articles
-
UHS Offers HPV VaccineHarvard University Health Services (UHS) will offer female students vaccinations to protect against cervical cancer and genital warts. The vaccines
-
A Welcome PharmaceuticalIt’s not anything close to a leap back to the era of free love, but it is a step toward
-
Student Groups Push HPV EducationTwo months after Harvard University Health Services (UHS) started offering human papillomavirus vaccine, several campus groups have mounted a drive
-
The Why of the NeedleNo, you heard right. In their approaches to distributing the new human papillomavirus (HPV) vaccine, Massachusetts has taken a laissez-faire
-
The Cost of (Not Getting) CancerUndergraduates who rush out to inoculate themselves with Gardasil, the new HPV or “cervical cancer” vaccine, are in for an
-
UHS To Offer Cheap VaccineAfter months of lobbying by students for price reductions, Harvard University Health Services (UHS) said yesterday that it would offer